Robert Hawver
Medical · Pembroke Pines, FLNPI 1295900132
Payments from drug & device makers
Across 673 payments — averaging $20.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$2K
- Mallinckrodt Hospital Products Inc.$1K
- Regeneron Healthcare Solutions, Inc.$860
- Boehringer Ingelheim$816
- United Therapeutics Corporation$776
- plus $6K from 26 others
What the payments were for
- Food & beverage$13,45199%
- Education$1731%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 149 | $2,164 |
| AstraZeneca | 81 | $1,850 |
| Mallinckrodt Hospital Products Inc. | 59 | $1,236 |
| Regeneron Healthcare Solutions, Inc. | 40 | $860 |
| Boehringer Ingelheim | 39 | $816 |
| United Therapeutics Corporation | 35 | $776 |
| Actelion Pharmaceuticals US, Inc. | 23 | $736 |
| Mylan Specialty L.p. | 32 | $718 |
| Sanofi | 35 | $701 |
| Insmed, Inc. | 27 | $528 |
| Baxter Healthcare | 20 | $470 |
| ANI Pharmaceuticals, Inc. | 17 | $387 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $331 |
| Verona Pharma, Inc. | 22 | $297 |
| Amgen | 16 | $285 |
| Viatris Specialty LLC | 11 | $264 |
| Grifols USA, LLC | 11 | $259 |
| Inogen, Inc. | 7 | $192 |
| Merck | 6 | $185 |
| Novartis | 6 | $125 |
| Bayer | 6 | $115 |
| Jazz Pharmaceuticals Inc. | 2 | $51 |
| Johnson & Johnson | 2 | $45 |
| Pfizer | 2 | $39 |
| Nabriva Therapeutics, PLC | 2 | $38 |
| Optinose US, Inc. | 2 | $34 |
| Sanofi Pasteur Inc. | 1 | $31 |
| Pulmonx Corporation | 1 | $25 |
| Advanced Respiratory, Inc | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Vapotherm Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,624 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 34 | $438,633 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 338 | $320,398 |
| AdempasRiociguat | 13 | $144,548 |
| Orenitram ErTreprostinil Diolamine | 13 | $133,365 |
| Dupixent PenDupilumab | 25 | $99,909 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 92 | $64,478 |
| TezspireTezepelumab-Ekko | 13 | $56,975 |
| Spiriva RespimatTiotropium Bromide | 60 | $38,006 |
| Breo ElliptaFluticasone/Vilanterol | 38 | $20,969 |
| SymbicortBudesonide/Formoterol Fumarate | 74 | $18,968 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 24 | $10,826 |
| Atrovent HfaIpratropium Bromide | 19 | $9,680 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 310 | $9,275 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 35 | $5,638 |
| Wixela InhubFluticasone Propion/Salmeterol | 35 | $5,268 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat | $816 | $476,63994 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $2,164 | $352,192400 claims |
| BayerAdempas | $115 | $144,54813 claims |
| AstraZenecaBreztri Aerosphere, Tezspire, Symbicort | $1,850 | $140,422179 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,031 medical providers in Florida.
Other medical in Pembroke Pines
- Lynette Weitman NicholsonPembroke Pines$49K
- Ricardo SaizPembroke Pines$22K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.